Ad5/3-Cox2L-D24

AXP000069.1 · Oncolytic virus

Platform
adenovirus (Ad5/3 chimera, Cox-2 promoter, Delta-24)
Originator
University of Helsinki (Akseli Hemminki)

Names

NameTypeSource
Ad5/3-Cox2L-D24preferred name, codecurator, paper

Virus

Role
Oncolytic
Family
Adenoviridae
Virus
human adenovirus 5 (NCBI Taxonomy 28285)
Strain
Ad5/3 chimera
Replication
conditionally replicating
Modifications
long cyclooxygenase-2 promoter drives E1A; Delta-24; Ad3 fiber knob
Route
intratumoral, intraperitoneal, intrapleural, intravenous
Source
evidence

Approvals

No regulatory approval recorded.

Clinical trials (0)

No trial in the latest ClinicalTrials.gov snapshot names this program.

Recent changes

No changes recorded in its trials yet.

Clinical papers

No confirmed clinical papers yet.

Other papers

Preclinical studies, reviews and other papers that name it.

PubMedTitleJournalYearLinked by
PMID 20237509Prolonged systemic circulation of chimeric oncolytic adenovirus Ad5/3-Cox2L-D24 in patients with metastatic and refractory solid tumors.Gene therapy2010name in title: Ad5/3-Cox2L-D24
PMID 18632604Tissue-specific promoters active in CD44+CD24-/low breast cancer cells.Cancer research2008name in abstract: Ad5/3-Cox2L-D24

Notes

ATAP construct (2007-2012); unarmed, replication controlled by a long cyclooxygenase-2 promoter.

How to cite

Ad5/3-Cox2L-D24 (AXP000069.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000069.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.